Illumina Inc. (ILMN) Rises 3.91% for January 09

Equities Staff  |

Among the biggest risers on the S&P 500 on Wednesday January 09 was Illumina Inc. ($ILMN), popping some 3.91% to a price of $305.24 a share with some 1.22 million shares trading hands.

Starting the day trading at $296.20, Illumina Inc. reached an intraday high of $306.13 and hit intraday lows of $295.50. Shares gained $11.49 apiece by day’s end. Over the last 90 days, the stock’s average daily volume has been n/a of its 147 million share total float. Today’s action puts the stock’s 50-day SMA at $n/a and 200-day SMA at $n/a with a 52-week range of $207.51 to $372.61.

Illumina is a major player in life science tools for analyzing genetic material. Revenue from microarray and genome sequencing machines and disposables make up most of the company's revenue, but approximately 18% of the company's sales come from testing services. Essentially all of Illumina's growth stems from the company's genome sequencing products, which include the company's high-throughput NovaSeq and HiSeq instruments in addition to its benchtop NextSeq, MiSeq, and MiniSeq, and iSeq product lines.

Illumina Inc. has its corporate headquarters located in San Diego, CA and employs 6,200 people. Its market cap has now risen to $44.87 billion after today’s trading, its P/E ratio is now 64.6, its P/S 13.32, P/B 12.81, and P/FCF n/a.

You can find a complete fundamental analysis of this stock at our For a complete fundamental analysis analysis of Illumina Inc., check out Stock Valuation Analysis tool for ILMN.

Still paying commissions on stock trades? now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by

The Dow Jones Industrial Average (DJIA) is the most visible stock index in the United States, but that doesn’t make it the best. In fact, the industry standard for market watchers and institutional investors in gauging portfolio performance is the S&P 500.

The DJIA relies on just 30 stocks as a sample of large- and mega-cap firms, dwarfed by the 500 contained in the S&P 500, and it also weights its returns using an outdated and flawed price-weighting method. The S&P 500’s weighting is based on market cap, making it a much better representation of actual market performance for large- and mega-cap stocks.

To get more information on Illumina Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: ILMN’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Ben Yablon Executive VP Salt Lending

Matt Bird sits down with Ben Yablon - Executive VP of Salt Lending - at the World Economic Forum in Davos January 2019

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…